nodes	percent_of_prediction	percent_of_DWPC	metapath
Solifenacin—CYP3A4—Esomeprazole—Barrett's esophagus	0.281	0.629	CbGbCtD
Solifenacin—CYP3A4—Omeprazole—Barrett's esophagus	0.166	0.371	CbGbCtD
Solifenacin—Foetor hepaticus—Omeprazole—Barrett's esophagus	0.0142	0.0272	CcSEcCtD
Solifenacin—Foetor hepaticus—Esomeprazole—Barrett's esophagus	0.0142	0.0272	CcSEcCtD
Solifenacin—Liver disorder—Esomeprazole—Barrett's esophagus	0.0119	0.0226	CcSEcCtD
Solifenacin—Liver disorder—Omeprazole—Barrett's esophagus	0.0119	0.0226	CcSEcCtD
Solifenacin—Gastrooesophageal reflux disease—Esomeprazole—Barrett's esophagus	0.00894	0.0171	CcSEcCtD
Solifenacin—Gastrooesophageal reflux disease—Omeprazole—Barrett's esophagus	0.00894	0.0171	CcSEcCtD
Solifenacin—Hepatocellular injury—Esomeprazole—Barrett's esophagus	0.00808	0.0154	CcSEcCtD
Solifenacin—Hepatocellular injury—Omeprazole—Barrett's esophagus	0.00808	0.0154	CcSEcCtD
Solifenacin—Cystitis noninfective—Omeprazole—Barrett's esophagus	0.00789	0.0151	CcSEcCtD
Solifenacin—Cystitis noninfective—Esomeprazole—Barrett's esophagus	0.00789	0.0151	CcSEcCtD
Solifenacin—Cystitis—Esomeprazole—Barrett's esophagus	0.0078	0.0149	CcSEcCtD
Solifenacin—Cystitis—Omeprazole—Barrett's esophagus	0.0078	0.0149	CcSEcCtD
Solifenacin—CHRM1—Secretion of Hydrochloric Acid in Parietal Cells—ATP4A—Barrett's esophagus	0.00764	0.258	CbGpPWpGaD
Solifenacin—Dry eye—Esomeprazole—Barrett's esophagus	0.00746	0.0142	CcSEcCtD
Solifenacin—Dry eye—Omeprazole—Barrett's esophagus	0.00746	0.0142	CcSEcCtD
Solifenacin—Bladder pain—Omeprazole—Barrett's esophagus	0.0073	0.0139	CcSEcCtD
Solifenacin—Bladder pain—Esomeprazole—Barrett's esophagus	0.0073	0.0139	CcSEcCtD
Solifenacin—Renal impairment—Esomeprazole—Barrett's esophagus	0.00616	0.0118	CcSEcCtD
Solifenacin—Renal impairment—Omeprazole—Barrett's esophagus	0.00616	0.0118	CcSEcCtD
Solifenacin—CHRM1—Secretion of Hydrochloric Acid in Parietal Cells—GAST—Barrett's esophagus	0.0061	0.206	CbGpPWpGaD
Solifenacin—Dry skin—Omeprazole—Barrett's esophagus	0.00537	0.0103	CcSEcCtD
Solifenacin—Dry skin—Esomeprazole—Barrett's esophagus	0.00537	0.0103	CcSEcCtD
Solifenacin—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.00536	0.0102	CcSEcCtD
Solifenacin—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.00536	0.0102	CcSEcCtD
Solifenacin—Muscular weakness—Omeprazole—Barrett's esophagus	0.00517	0.00988	CcSEcCtD
Solifenacin—Muscular weakness—Esomeprazole—Barrett's esophagus	0.00517	0.00988	CcSEcCtD
Solifenacin—Influenza—Esomeprazole—Barrett's esophagus	0.00507	0.00968	CcSEcCtD
Solifenacin—Influenza—Omeprazole—Barrett's esophagus	0.00507	0.00968	CcSEcCtD
Solifenacin—Dysuria—Omeprazole—Barrett's esophagus	0.00474	0.00905	CcSEcCtD
Solifenacin—Dysuria—Esomeprazole—Barrett's esophagus	0.00474	0.00905	CcSEcCtD
Solifenacin—Infestation—Omeprazole—Barrett's esophagus	0.00452	0.00863	CcSEcCtD
Solifenacin—Infestation NOS—Omeprazole—Barrett's esophagus	0.00452	0.00863	CcSEcCtD
Solifenacin—Infestation—Esomeprazole—Barrett's esophagus	0.00452	0.00863	CcSEcCtD
Solifenacin—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00452	0.00863	CcSEcCtD
Solifenacin—Depression—Esomeprazole—Barrett's esophagus	0.00451	0.0086	CcSEcCtD
Solifenacin—Depression—Omeprazole—Barrett's esophagus	0.00451	0.0086	CcSEcCtD
Solifenacin—Renal failure—Omeprazole—Barrett's esophagus	0.00444	0.00848	CcSEcCtD
Solifenacin—Renal failure—Esomeprazole—Barrett's esophagus	0.00444	0.00848	CcSEcCtD
Solifenacin—Urinary tract infection—Omeprazole—Barrett's esophagus	0.00439	0.00839	CcSEcCtD
Solifenacin—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.00439	0.00839	CcSEcCtD
Solifenacin—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.00427	0.00816	CcSEcCtD
Solifenacin—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.00427	0.00816	CcSEcCtD
Solifenacin—Hallucination—Omeprazole—Barrett's esophagus	0.00404	0.00771	CcSEcCtD
Solifenacin—Hallucination—Esomeprazole—Barrett's esophagus	0.00404	0.00771	CcSEcCtD
Solifenacin—Pharyngitis—Omeprazole—Barrett's esophagus	0.00403	0.00769	CcSEcCtD
Solifenacin—Pharyngitis—Esomeprazole—Barrett's esophagus	0.00403	0.00769	CcSEcCtD
Solifenacin—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.00401	0.00765	CcSEcCtD
Solifenacin—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.00401	0.00765	CcSEcCtD
Solifenacin—Oedema peripheral—Omeprazole—Barrett's esophagus	0.004	0.00763	CcSEcCtD
Solifenacin—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.004	0.00763	CcSEcCtD
Solifenacin—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.00399	0.00761	CcSEcCtD
Solifenacin—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.00399	0.00761	CcSEcCtD
Solifenacin—Urethral disorder—Omeprazole—Barrett's esophagus	0.00398	0.00759	CcSEcCtD
Solifenacin—Urethral disorder—Esomeprazole—Barrett's esophagus	0.00398	0.00759	CcSEcCtD
Solifenacin—Erythema multiforme—Omeprazole—Barrett's esophagus	0.00384	0.00732	CcSEcCtD
Solifenacin—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.00384	0.00732	CcSEcCtD
Solifenacin—Eye disorder—Omeprazole—Barrett's esophagus	0.00379	0.00724	CcSEcCtD
Solifenacin—Eye disorder—Esomeprazole—Barrett's esophagus	0.00379	0.00724	CcSEcCtD
Solifenacin—Immune system disorder—Omeprazole—Barrett's esophagus	0.00366	0.007	CcSEcCtD
Solifenacin—Immune system disorder—Esomeprazole—Barrett's esophagus	0.00366	0.007	CcSEcCtD
Solifenacin—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00366	0.00698	CcSEcCtD
Solifenacin—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00366	0.00698	CcSEcCtD
Solifenacin—Mental disorder—Omeprazole—Barrett's esophagus	0.00355	0.00679	CcSEcCtD
Solifenacin—Mental disorder—Esomeprazole—Barrett's esophagus	0.00355	0.00679	CcSEcCtD
Solifenacin—Malnutrition—Esomeprazole—Barrett's esophagus	0.00353	0.00674	CcSEcCtD
Solifenacin—Malnutrition—Omeprazole—Barrett's esophagus	0.00353	0.00674	CcSEcCtD
Solifenacin—Dysgeusia—Esomeprazole—Barrett's esophagus	0.00346	0.0066	CcSEcCtD
Solifenacin—Dysgeusia—Omeprazole—Barrett's esophagus	0.00346	0.0066	CcSEcCtD
Solifenacin—Vision blurred—Omeprazole—Barrett's esophagus	0.00333	0.00635	CcSEcCtD
Solifenacin—Vision blurred—Esomeprazole—Barrett's esophagus	0.00333	0.00635	CcSEcCtD
Solifenacin—Angioedema—Omeprazole—Barrett's esophagus	0.00323	0.00616	CcSEcCtD
Solifenacin—Angioedema—Esomeprazole—Barrett's esophagus	0.00323	0.00616	CcSEcCtD
Solifenacin—Palpitations—Omeprazole—Barrett's esophagus	0.00312	0.00596	CcSEcCtD
Solifenacin—Palpitations—Esomeprazole—Barrett's esophagus	0.00312	0.00596	CcSEcCtD
Solifenacin—Cough—Omeprazole—Barrett's esophagus	0.00308	0.00588	CcSEcCtD
Solifenacin—Cough—Esomeprazole—Barrett's esophagus	0.00308	0.00588	CcSEcCtD
Solifenacin—Hypertension—Omeprazole—Barrett's esophagus	0.00305	0.00582	CcSEcCtD
Solifenacin—Hypertension—Esomeprazole—Barrett's esophagus	0.00305	0.00582	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00299	0.0057	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00299	0.0057	CcSEcCtD
Solifenacin—Dry mouth—Esomeprazole—Barrett's esophagus	0.00294	0.00561	CcSEcCtD
Solifenacin—Dry mouth—Omeprazole—Barrett's esophagus	0.00294	0.00561	CcSEcCtD
Solifenacin—Confusional state—Esomeprazole—Barrett's esophagus	0.00291	0.00555	CcSEcCtD
Solifenacin—Confusional state—Omeprazole—Barrett's esophagus	0.00291	0.00555	CcSEcCtD
Solifenacin—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.00288	0.0055	CcSEcCtD
Solifenacin—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.00288	0.0055	CcSEcCtD
Solifenacin—Infection—Omeprazole—Barrett's esophagus	0.00286	0.00547	CcSEcCtD
Solifenacin—Infection—Esomeprazole—Barrett's esophagus	0.00286	0.00547	CcSEcCtD
Solifenacin—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00283	0.0054	CcSEcCtD
Solifenacin—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00283	0.0054	CcSEcCtD
Solifenacin—Tachycardia—Esomeprazole—Barrett's esophagus	0.00281	0.00537	CcSEcCtD
Solifenacin—Tachycardia—Omeprazole—Barrett's esophagus	0.00281	0.00537	CcSEcCtD
Solifenacin—Skin disorder—Esomeprazole—Barrett's esophagus	0.0028	0.00535	CcSEcCtD
Solifenacin—Skin disorder—Omeprazole—Barrett's esophagus	0.0028	0.00535	CcSEcCtD
Solifenacin—Somnolence—Esomeprazole—Barrett's esophagus	0.00256	0.00489	CcSEcCtD
Solifenacin—Somnolence—Omeprazole—Barrett's esophagus	0.00256	0.00489	CcSEcCtD
Solifenacin—Dyspepsia—Esomeprazole—Barrett's esophagus	0.00254	0.00484	CcSEcCtD
Solifenacin—Dyspepsia—Omeprazole—Barrett's esophagus	0.00254	0.00484	CcSEcCtD
Solifenacin—Decreased appetite—Omeprazole—Barrett's esophagus	0.00251	0.00478	CcSEcCtD
Solifenacin—Decreased appetite—Esomeprazole—Barrett's esophagus	0.00251	0.00478	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00249	0.00475	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.00249	0.00475	CcSEcCtD
Solifenacin—Fatigue—Omeprazole—Barrett's esophagus	0.00248	0.00474	CcSEcCtD
Solifenacin—Fatigue—Esomeprazole—Barrett's esophagus	0.00248	0.00474	CcSEcCtD
Solifenacin—Constipation—Esomeprazole—Barrett's esophagus	0.00246	0.00471	CcSEcCtD
Solifenacin—Constipation—Omeprazole—Barrett's esophagus	0.00246	0.00471	CcSEcCtD
Solifenacin—Feeling abnormal—Omeprazole—Barrett's esophagus	0.00237	0.00453	CcSEcCtD
Solifenacin—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.00237	0.00453	CcSEcCtD
Solifenacin—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.00236	0.0045	CcSEcCtD
Solifenacin—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.00236	0.0045	CcSEcCtD
Solifenacin—Urticaria—Omeprazole—Barrett's esophagus	0.00229	0.00437	CcSEcCtD
Solifenacin—Urticaria—Esomeprazole—Barrett's esophagus	0.00229	0.00437	CcSEcCtD
Solifenacin—Abdominal pain—Esomeprazole—Barrett's esophagus	0.00228	0.00435	CcSEcCtD
Solifenacin—Abdominal pain—Omeprazole—Barrett's esophagus	0.00228	0.00435	CcSEcCtD
Solifenacin—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.00212	0.00405	CcSEcCtD
Solifenacin—Hypersensitivity—Omeprazole—Barrett's esophagus	0.00212	0.00405	CcSEcCtD
Solifenacin—Asthenia—Omeprazole—Barrett's esophagus	0.00207	0.00395	CcSEcCtD
Solifenacin—Asthenia—Esomeprazole—Barrett's esophagus	0.00207	0.00395	CcSEcCtD
Solifenacin—Pruritus—Esomeprazole—Barrett's esophagus	0.00204	0.00389	CcSEcCtD
Solifenacin—Pruritus—Omeprazole—Barrett's esophagus	0.00204	0.00389	CcSEcCtD
Solifenacin—Dizziness—Omeprazole—Barrett's esophagus	0.00191	0.00364	CcSEcCtD
Solifenacin—Dizziness—Esomeprazole—Barrett's esophagus	0.00191	0.00364	CcSEcCtD
Solifenacin—Vomiting—Omeprazole—Barrett's esophagus	0.00183	0.0035	CcSEcCtD
Solifenacin—Vomiting—Esomeprazole—Barrett's esophagus	0.00183	0.0035	CcSEcCtD
Solifenacin—Rash—Esomeprazole—Barrett's esophagus	0.00182	0.00347	CcSEcCtD
Solifenacin—Rash—Omeprazole—Barrett's esophagus	0.00182	0.00347	CcSEcCtD
Solifenacin—Dermatitis—Omeprazole—Barrett's esophagus	0.00182	0.00347	CcSEcCtD
Solifenacin—Dermatitis—Esomeprazole—Barrett's esophagus	0.00182	0.00347	CcSEcCtD
Solifenacin—Headache—Omeprazole—Barrett's esophagus	0.00181	0.00345	CcSEcCtD
Solifenacin—Headache—Esomeprazole—Barrett's esophagus	0.00181	0.00345	CcSEcCtD
Solifenacin—Nausea—Esomeprazole—Barrett's esophagus	0.00171	0.00327	CcSEcCtD
Solifenacin—Nausea—Omeprazole—Barrett's esophagus	0.00171	0.00327	CcSEcCtD
Solifenacin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00095	0.0321	CbGpPWpGaD
Solifenacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000546	0.0184	CbGpPWpGaD
Solifenacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000546	0.0184	CbGpPWpGaD
Solifenacin—CHRM1—Circadian rythm related genes—CRTC1—Barrett's esophagus	0.000488	0.0165	CbGpPWpGaD
Solifenacin—CHRM5—G alpha (q) signalling events—GAST—Barrett's esophagus	0.000478	0.0161	CbGpPWpGaD
Solifenacin—CHRM4—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000459	0.0155	CbGpPWpGaD
Solifenacin—CHRM5—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.00044	0.0148	CbGpPWpGaD
Solifenacin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000428	0.0144	CbGpPWpGaD
Solifenacin—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000378	0.0128	CbGpPWpGaD
Solifenacin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000347	0.0117	CbGpPWpGaD
Solifenacin—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000342	0.0115	CbGpPWpGaD
Solifenacin—CHRM1—G alpha (q) signalling events—GAST—Barrett's esophagus	0.000337	0.0114	CbGpPWpGaD
Solifenacin—CHRM3—G alpha (q) signalling events—GAST—Barrett's esophagus	0.000336	0.0113	CbGpPWpGaD
Solifenacin—CHRM1—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.00031	0.0105	CbGpPWpGaD
Solifenacin—CHRM3—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000309	0.0104	CbGpPWpGaD
Solifenacin—CHRM2—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000306	0.0103	CbGpPWpGaD
Solifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000301	0.0102	CbGpPWpGaD
Solifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.0003	0.0101	CbGpPWpGaD
Solifenacin—CHRM4—G alpha (i) signalling events—SST—Barrett's esophagus	0.000285	0.00963	CbGpPWpGaD
Solifenacin—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000281	0.00948	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.000263	0.00889	CbGpPWpGaD
Solifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000227	0.00765	CbGpPWpGaD
Solifenacin—CHRM4—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000217	0.00733	CbGpPWpGaD
Solifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000217	0.00733	CbGpPWpGaD
Solifenacin—CHRM5—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000208	0.00702	CbGpPWpGaD
Solifenacin—CHRM2—G alpha (i) signalling events—SST—Barrett's esophagus	0.00019	0.00641	CbGpPWpGaD
Solifenacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.00018	0.00606	CbGpPWpGaD
Solifenacin—CHRM4—GPCR ligand binding—SST—Barrett's esophagus	0.000173	0.00583	CbGpPWpGaD
Solifenacin—CHRM5—GPCR ligand binding—SST—Barrett's esophagus	0.000165	0.00558	CbGpPWpGaD
Solifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000153	0.00516	CbGpPWpGaD
Solifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000152	0.00514	CbGpPWpGaD
Solifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000151	0.00509	CbGpPWpGaD
Solifenacin—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.000149	0.00504	CbGpPWpGaD
Solifenacin—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000147	0.00497	CbGpPWpGaD
Solifenacin—CHRM1—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000146	0.00494	CbGpPWpGaD
Solifenacin—CHRM3—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000146	0.00493	CbGpPWpGaD
Solifenacin—CHRM2—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000145	0.00488	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—GAST—Barrett's esophagus	0.000142	0.00481	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—GAST—Barrett's esophagus	0.000136	0.0046	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—GAST—Barrett's esophagus	0.000129	0.00436	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—GAST—Barrett's esophagus	0.000124	0.00418	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—SST—Barrett's esophagus	0.000116	0.00393	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—SST—Barrett's esophagus	0.000116	0.00392	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—SST—Barrett's esophagus	0.000115	0.00388	CbGpPWpGaD
Solifenacin—CHRM1—Circadian rythm related genes—PPARG—Barrett's esophagus	0.000111	0.00376	CbGpPWpGaD
Solifenacin—CHRM4—G alpha (i) signalling events—CXCL8—Barrett's esophagus	0.000111	0.00375	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	0.000103	0.00346	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—SST—Barrett's esophagus	9.76e-05	0.00329	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—GAST—Barrett's esophagus	9.6e-05	0.00324	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—GAST—Barrett's esophagus	9.57e-05	0.00323	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—GAST—Barrett's esophagus	9.47e-05	0.0032	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—SST—Barrett's esophagus	9.34e-05	0.00315	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—SST—Barrett's esophagus	8.86e-05	0.00299	CbGpPWpGaD
Solifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	8.83e-05	0.00298	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—GAST—Barrett's esophagus	8.72e-05	0.00294	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—GAST—Barrett's esophagus	8.69e-05	0.00293	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PTGES—Barrett's esophagus	8.61e-05	0.00291	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—GAST—Barrett's esophagus	8.6e-05	0.0029	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—SST—Barrett's esophagus	8.48e-05	0.00286	CbGpPWpGaD
Solifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	8.46e-05	0.00286	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—GAST—Barrett's esophagus	7.64e-05	0.00258	CbGpPWpGaD
Solifenacin—CHRM2—G alpha (i) signalling events—CXCL8—Barrett's esophagus	7.39e-05	0.0025	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—GAST—Barrett's esophagus	7.31e-05	0.00247	CbGpPWpGaD
Solifenacin—CHRM4—GPCR ligand binding—CXCL8—Barrett's esophagus	6.73e-05	0.00227	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—SST—Barrett's esophagus	6.58e-05	0.00222	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—SST—Barrett's esophagus	6.56e-05	0.00221	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CYP26A1—Barrett's esophagus	6.53e-05	0.0022	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—SST—Barrett's esophagus	6.49e-05	0.00219	CbGpPWpGaD
Solifenacin—CHRM5—GPCR ligand binding—CXCL8—Barrett's esophagus	6.44e-05	0.00217	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—SST—Barrett's esophagus	5.97e-05	0.00202	CbGpPWpGaD
Solifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	5.96e-05	0.00201	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—SST—Barrett's esophagus	5.95e-05	0.00201	CbGpPWpGaD
Solifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	5.94e-05	0.002	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—SST—Barrett's esophagus	5.9e-05	0.00199	CbGpPWpGaD
Solifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	5.88e-05	0.00198	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—SST—Barrett's esophagus	5.23e-05	0.00177	CbGpPWpGaD
Solifenacin—CHRM1—Circadian rythm related genes—TP53—Barrett's esophagus	5.21e-05	0.00176	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—GAST—Barrett's esophagus	5.15e-05	0.00174	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—GAST—Barrett's esophagus	5.13e-05	0.00173	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—GAST—Barrett's esophagus	5.08e-05	0.00172	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—SST—Barrett's esophagus	5.01e-05	0.00169	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—SLC9A1—Barrett's esophagus	4.71e-05	0.00159	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—CXCL8—Barrett's esophagus	4.53e-05	0.00153	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—CXCL8—Barrett's esophagus	4.52e-05	0.00153	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—CXCL8—Barrett's esophagus	4.48e-05	0.00151	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—CXCL8—Barrett's esophagus	3.8e-05	0.00128	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—CXCL8—Barrett's esophagus	3.64e-05	0.00123	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—SST—Barrett's esophagus	3.53e-05	0.00119	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—SST—Barrett's esophagus	3.52e-05	0.00119	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—SST—Barrett's esophagus	3.48e-05	0.00118	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—CXCL8—Barrett's esophagus	3.45e-05	0.00117	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PTGES—Barrett's esophagus	3.37e-05	0.00114	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—CXCL8—Barrett's esophagus	3.31e-05	0.00112	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—APC—Barrett's esophagus	2.77e-05	0.000935	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—APC—Barrett's esophagus	2.65e-05	0.000895	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.56e-05	0.000865	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.55e-05	0.000862	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	2.55e-05	0.000862	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.53e-05	0.000854	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CXCL8—Barrett's esophagus	2.33e-05	0.000786	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CXCL8—Barrett's esophagus	2.32e-05	0.000783	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CXCL8—Barrett's esophagus	2.3e-05	0.000776	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—RELA—Barrett's esophagus	2.16e-05	0.00073	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PPARG—Barrett's esophagus	2.15e-05	0.000725	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—RELA—Barrett's esophagus	2.07e-05	0.000699	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CXCL8—Barrett's esophagus	2.04e-05	0.000688	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CXCL8—Barrett's esophagus	1.95e-05	0.000659	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—APC—Barrett's esophagus	1.87e-05	0.00063	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—APC—Barrett's esophagus	1.86e-05	0.000628	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—APC—Barrett's esophagus	1.84e-05	0.000622	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.84e-05	0.000621	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PTGS2—Barrett's esophagus	1.69e-05	0.000571	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—RELA—Barrett's esophagus	1.46e-05	0.000493	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—RELA—Barrett's esophagus	1.45e-05	0.000491	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—RELA—Barrett's esophagus	1.44e-05	0.000486	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CXCL8—Barrett's esophagus	1.37e-05	0.000464	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CXCL8—Barrett's esophagus	1.37e-05	0.000463	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CXCL8—Barrett's esophagus	1.36e-05	0.000458	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TP53—Barrett's esophagus	1.25e-05	0.000422	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TP53—Barrett's esophagus	1.2e-05	0.000405	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TP53—Barrett's esophagus	8.44e-06	0.000285	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TP53—Barrett's esophagus	8.41e-06	0.000284	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PPARG—Barrett's esophagus	8.4e-06	0.000284	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TP53—Barrett's esophagus	8.33e-06	0.000281	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	6.61e-06	0.000223	CbGpPWpGaD
